References
- Luersen K, Dabade TS, West CE, et al. Phototherapy trends in dermatology. J Dermatolog Treat. 2014;25(6):487–488.
- Aubin F, Chaignot C, Gallais-Serezal I. Decline in the use of phototherapy in France from 2010 to 2019. Br J Dermatol. 2021;185(3):662–663.
- Brownstone ND, Hong J, Mosca M, et al. Biologic treatments of psoriasis: an update for the clinician. Biologics. 2021;15:39–51.
- Singh P, Silverberg JI. Real-world trends in biologic, oral systemic, and phototherapy in US patients with psoriasis or psoriatic arthritis. J Am Acad Dermatol. 2020;83(1):256–257.
- Williams E, Burkemper N. Cost as potential barrier to phototherapy for treatment of psoriasis. J Am Acad Dermatol. 2017;76(6):AB85.
- Ratchataswan T, Banzon TM, Thyssen JP, et al. Biologics for treatment of atopic dermatitis: current status and future prospect. J Allergy Clin Immunol Pract. 2021;9(3):1053–1065.
- Nutten S. Atopic dermatitis: global epidemiology and risk factors. Ann Nutr Metab. 2015;66(1):8–16.
- Goyal K, Nguyen MO, Reynolds RV, et al. Perceptions of U.S. dermatology residency program directors regarding the adequacy of phototherapy training during residency. Photodermatol Photoimmunol Photomed. 2017;33(6):321–325.
- Torres AE, Lyons AB, Hamzavi IH, et al. Role of phototherapy in the era of biologics. J Am Acad Dermatol. 2021;84(2):479–485.